# A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A

> clinical trial · VERIFIED · 2026-08-06

Status: RECRUITING · Sponsor: Hoffmann-La Roche · Condition: Hemophilia A

- Company: Hoffmann-La Roche
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT07416526

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.